Case Report: Good cardiac tolerance to Toripalimab in a CVD patient with oral melanoma

Conclusions: This case provided evidence of Toripalimab combined with chemotherapy on melanoma patients with complex cardiovascular diseases. Toripalimab demonstrated a manageable safety profile and durable clinical response. In addition, the standard CHF treatment plays a vital role in the protection of cardiac function. In a cancer patient with complex cardiovascular diseases, standard prophylactic CHF treatment should be applied at an early stage.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research